None listed
Conditions
Interventions
None listed
Sponsors
Seoul National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who received successful percutaneous angioplasty using DES or DCB for the causative lesion (the criterion for successful angioplasty was defined as the case where the target coronary artery TMI III blood flow and residual lesion stenosis were less than 30%).
Exclusion criteria
Exclusion criteria: 1) Ongoing end-stage heart failure or symptoms of heart failure (Killip class II or higher or left ventricular ejection rate <20% on echocardiography) 2) Patients with uncontrolled ischemia such as repetitive pain or repetitive ischemic electrocardiogram changes 3) Patients with uncontrolled ventricular arrhythmia 4) Symptoms of malignant tumors in which myocardial infarction treatment is clinically insignificant 5) Signs of a serious infectious disease 6) Pregnant or lactating patients 7) Participants in other clinical studies who disallow stem cell treatment for myocardial infarction (this treatment can be implemented if the patient voluntarily withdraws consent from other clinical studies)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left ventricular ejection rate and wall motion score index measured by echocardiography | — |
Secondary
| Measure | Time frame |
|---|---|
| MACE: death, revascularization of target lesions, readmission, changes in BNP, evaluated by SPECT left ventricular ejection rate and wall motion score index, 6-minute walking ability test results | — |
Countries
Korea, Republic of
Contacts
Public ContactEunhye Kim
Seoul National University Hospital
Outcome results
None listed